[ad_1]
Repro-Med Systems (OTCMKTS:REPR) and Restoration Robotics (NASDAQ:HAIR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation.
Analyst Recommendations
This is a breakdown of recent ratings and recommmendations for Repro-Med Systems and Restoration Robotics, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Repro-Med Systems | 0 | 0 | 0 | 0 | N/A |
Restoration Robotics | 0 | 0 | 3 | 0 | 3.00 |
Restoration Robotics has a consensus target price of $8.50, indicating a potential upside of 888.37%. Given Restoration Robotics’ higher possible upside, analysts plainly believe Restoration Robotics is more favorable than Repro-Med Systems.
Insider & Institutional Ownership
0.0% of Repro-Med Systems shares are owned by institutional investors. Comparatively, 31.2% of Restoration Robotics shares are owned by institutional investors. 48.0% of Repro-Med Systems shares are owned by company insiders. Comparatively, 37.8% of Restoration Robotics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Volatility and Risk
Repro-Med Systems has a beta of -0.83, indicating that its stock price is 183% less volatile than the S&P 500. Comparatively, Restoration Robotics has a beta of 4.98, indicating that its stock price is 398% more volatile than the S&P 500.
Profitability
This table compares Repro-Med Systems and Restoration Robotics’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Repro-Med Systems | N/A | N/A | N/A |
Restoration Robotics | -103.09% | -324.32% | -75.33% |
Earnings and Valuation
This table compares Repro-Med Systems and Restoration Robotics’ revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Repro-Med Systems | N/A | N/A | N/A | N/A | N/A |
Restoration Robotics | $21.30 million | 1.64 | -$17.84 million | ($2.50) | -0.34 |
Repro-Med Systems has higher earnings, but lower revenue than Restoration Robotics.
Summary
Restoration Robotics beats Repro-Med Systems on 5 of the 9 factors compared between the two stocks.
About Repro-Med Systems
Repro Med Systems, Inc. designs, manufactures, and markets proprietary portable medical devices and supplies primarily for the ambulatory infusion market and emergency medical applications worldwide. The company offers mechanical infusion product FREEDOM infusion systems, which include the FREEDOM60 syringe infusion driver, the FreedomEdge syringe infusion driver, HIgH-Flo subcutaneous safety needle sets, RMS precision flow rate tubing, and RMS precision flow rate controller, as well as medical suction product RES-Q-VAC, a portable medical suction system. The company sells its products directly to physician offices, hospitals, and other institutional customers, as well as through regional distributors specializing in the hospital respiratory care market. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.
About Restoration Robotics
Restoration Robotics, Inc., a medical device company, develops and commercializes image-guided robotic systems in the United States and internationally. The company offers ARTAS System, a physician-assisted robotic system that identifies and dissects hair follicular units directly from the scalp and creates recipient implant sites. Its system includes the ARTAS Hair Studio application, an interactive three-dimensional patient consultation tool that enables a physician to create a simulated hair transplant model for use in patient consultations. The company was founded in 2002 and is headquartered in San Jose, California.
Receive News & Ratings for Repro-Med Systems Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Repro-Med Systems and related companies with MarketBeat.com’s FREE daily email newsletter.
[ad_2]
Source link
Leave A Comment
You must be logged in to post a comment.